AzTrials
AzTrials

OverweightNCT01628835

Low Glycemic Index (GI) Diet Management for Pregnant Woman With Overweight

A study testing Low dietary glycemic index diet and National recommendation diet in people with Overweight and Pregnant Women, run by Children's Hospital of Fudan University at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is a randomized, single-blinded, controlled intervention trial to compare the effect of a low glycemic index diet versus diet recommended by the Chinese Dietary Guide for Pregnant Women on maternal and neonatal insulin resistance and adverse gestational events. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Overweight, Pregnant Women
What is being tested?
Low dietary glycemic index diet and National recommendation diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
2 sitesChina
Study dates
Jun 2012to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Singleton pregnancy;
  • Pregnant women with BMI≥24 kg/m2 at first antenatal examination;
  • aged 18 years to 45 years;
  • The week of first prenatal examination equal to or less than 12 weeks;
  • Take routine prenatal examination;
  • Willing and able to give informed consent. Exclusion
Show all 9Show fewer
  • Artificial impregnation;
  • History of hypertension, diabetes, coronary heart disease or mental disorder;
  • With Special diet habit(e.g. vegetarianism/ veganism).

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Kunshan Maternal and Child Health Care Hospital

    Kunshan, Jiangsu

  • International Peace Maternity and Child Care Centers of Communications University

    Shanghai, 201102

Other trials in China

About this study

Official title: Low Glycemic Index Diet Intervention on Insulin Resistance of Overweight Pregnant Women.

The study is a randomized, single-blinded, controlled intervention trial to compare the effect of a low glycemic index diet versus diet recommended by the Chinese Dietary Guide for Pregnant Women on maternal and neonatal insulin resistance and adverse gestational events.

Read the detailed description

Overweight in pregnant women increases maternal insulin resistance and risk of adverse pregnancy outcomes. Recent evidence from both animal studies and human subject studies shows that adverse environmental exposures during pregnancy result in adverse influence on offsprings. The hypothesis of the current study is that the healthy intervention during pregnancy to overweight pregnant women--low glycemic diet, may improve the maternal and neonatal insulin resistance at birth.

The current study adopts randomized, single-blinded, controlled intervention trial, gives low glycemic index diet intervention based on the national diet and physical activity recommendations for pregnant women to the intervention group and only national diet recommendations to the control group. Four diet consultation interviews will be done,at baseline (first prenatal examination), the end of the 1st trimester, the 2nd trimester and the 3rd trimester respectively, including diet assessment and diet consultation specifically to adopting low glycemic diet. Glycemic load of diet will be calculated based on 24 hour diet recall data for each individual at every visit to help to lower their diet glycemic load by modifying some daily foods. The effect of intervention is investigated by comparing the insulin resistance levels between the two arms at birth and when infants are at age 2. For discrete traits, such as incidence of gestational diabetes and gestational hypertension, Person's chi-square tests were used. For continuous traits, such as insulin resistance index, maternal weight gain and neonatal birth weight, we use t-tests for comparisons between two groups. The study expects that long-term low GI diet intervention have beneficial effects on controlling maternal and neonatal insulin resistance to overweight women and long term health.

Being tested
Low dietary glycemic index diet, National recommendation diet
Keywords
overweight, pregnancy, diet counselling, glycemic
Medical subject headings
Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low dietary glycemic index dietBehavioural

    Based on the national diet and physical activity recommendations for pregnant women (total energy intake, protein and vitamin etc.), counseling for a low dietary glycemic index diet will be provided

  • National recommendation dietBehavioural

    Also called recommended diet for pregnant women

    Provision of food and dietary counseling according to the national prenatal nutrition recommendation without GI information

Study groups in NCT01628835
Study groupRoleWhat they receive
Low dietary glycemic index dietExperimentalBased on the national diet and physical activity recommendations for pregnant women (total energy intake, protein and vitamin etc.), counseling for a low dietary glycemic index diet will be provided.
Receives: Behavioral: Low dietary glycemic index diet
National recommendation dietActive comparatorProvision of food and dietary counseling according to the national prenatal nutrition recommendation without GI information
Receives: Behavioral: National recommendation diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal insulin resistance

    Measured: During pregnancy

  2. Cord blood C-peptide

    Measured: at delivery

  3. Maternal weight gain

    measured before delivery (minus pre-conceptual body weight)

    Measured: measured before delivery

  4. Incidence of gestational diabetes

    from 1st antenatal visit to delivery

    Measured: during pregnancy

  5. Incidence of macrosomia

    birth weight >= 4000g

    Measured: at delivery

Secondary outcomes (6)
  1. Incidence of gestational hypertension

    proportion of patients with SBP/SBP>=140/90 for 3 visits

    Measured: during pregnancy

  2. Mean infant birth weight

    Measured: at delivery

  3. cesarean

    Measured: at delivery

  4. head circumference

    Measured: at delivery

  5. Mean gestational age

    Measured: at delivery

  6. Incidence of premature delivery

    gestational age <37 week at delivery

    Measured: at delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2012 (estimated)
  2. Study startJun 2012
  3. Primary completionFeb 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01628835
Sponsor's protocol ID
version1.0
Other IDs
NSFC 81273168
Status last verified
Aug 2016
First submitted
10 May 2012
Last updated
24 Aug 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Zhang Y, Wang L, Yang W, Niu D, Li C, Wang L, Gu P, Xia Y, Shen Y, Yan J, Zhao Q, Mu K, Yan W. Effectiveness of Low Glycemic Index Diet Consultations Through a Diet Glycemic Assessment App Tool on Maternal and Neonatal Insulin Resistance: A Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Apr 18;7(4):e12081. doi: 10.2196/12081.

    PubMed 30998227

Questions about this trial

What is this clinical trial studying?

A study testing Low dietary glycemic index diet and National recommendation diet in people with Overweight and Pregnant Women, run by Children's Hospital of Fudan University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal insulin resistance (time frame: During pregnancy). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01628835, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in